| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Testis |
a Dipartimento di Medicina Sperimentale, sez. "F. Bottazzi," 80138 Napoli, Italy
Evidence has been accumulated indicating that GnRH-like peptides are present in a variety of extrabrain areas of mammalian and nonmammalian vertebrates. A pioneer study carried out in the frog, Rana esculenta, demonstrated that testicular GnRH induced spermatogonial proliferation. Recently, we have shown that in proliferating spermatogonia (SPG) of frogs, a change of localization of the oncoprotein Fos, from the cytoplasm to the nucleus, occurs. This leads to the hypothesis that one or more testicular GnRH peptides may regulate SPG proliferation through Fos family proteins. Therefore, in vivo experiments in intact R. esculenta and in vitro incubations of testis fragments have been carried out using GnRH agonist (GnRHa; buserelin) and GnRH antagonist (D-pGlu1,D-Phe2,D-Trp3,6-GnRH). Cytoplasmic and nuclear Fos-like protein localization has been found by Western blot analysis in testicular extracts. Immunocytochemistry confirmed that cytoplasmic immunostaining was restricted to SPG; change of localization into the nuclear compartment was observed after GnRHa treatment. Northern blot analysis showed that treatments of testis fragments with GnRHa did not modify testicular c-fos mRNA expression. On the contrary, a Fos-like protein of 52 kDa, while not affected in vivo, disappeared from testicular cytosolic extracts after in vitro treatment with GnRHa. Contemporaneously, a 55-kDa Fos-related signal appeared in nuclear extracts. The GnRH antagonist counteracted the effects of GnRHa. Furthermore, in vivo treatments showed that GnRHa acted negatively on a 43-kDa nuclear Fos-related signal and that gonadotropins caused the decrease of 52-kDa cytoplasmic signal. In conclusion, we show, to our knowledge for the first time, that Fos is regulated by GnRHa directly (not through the pituitary) at the testicular level. The main effect appears to be related to Fos translocation from cytoplasmic to nuclear compartments of SPG.
2 Correspondence: Riccardo Pierantoni, Dipartimento Medicina Sperimentale, section "Filippo Bottazzi," Via Costantinopoli 16, 80138 Napoli, Italy. FAX: 39 081 5667536; e-mail: riccardo.pierantoni{at}unina2.it
This article has been cited by other articles:
|
|
 |
|
  G. Cobellis, G. Cacciola, D. Scarpa, R. Meccariello, R. Chianese, M. F. Franzoni, K. Mackie, R. Pierantoni, and S. Fasano Endocannabinoid System in Frog and Rodent Testis: Type-1 Cannabinoid Receptor and Fatty Acid Amide Hydrolase Activity in Male Germ Cells Biol Reprod, July 1, 2006; 75(1): 82 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hang Le, A. van der Wal, P. van der Bent, I. S. Lantinga-van Leeuwen, M. H. Breuning, H. van Dam, E. de Heer, and D. J.M. Peters Increased Activity of Activator Protein-1 Transcription Factor Components ATF2, c-Jun, and c-Fos in Human and Mouse Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2724 - 2731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cobellis, M. Lombardi, D. Scarpa, G. Izzo, G. Fienga, R. Meccariello, R. Pierantoni, and S. Fasano Fra1 Activity in the Frog, Rana esculenta, Testis: A New Potential Role in Sperm Transport Biol Reprod, May 1, 2005; 72(5): 1101 - 1108. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
